NCH is among the first to use a newly FDA-approved device designed to treat complex aortic aneurysms, providing a lifesaving option for patients facing this dangerous condition.
NCH is among the first to use a newly FDA-approved device designed to treat complex aortic aneurysms, providing a lifesaving option for patients facing this dangerous condition.